Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Bioorganic & Medicinal Chemistry Letters
2001.0
Abstract
Highly potent CCR3 antagonists have been developed from a previously reported series of phenylalanine ester-based leads. Solution-phase, parallel synthesis optimization was utilized to identify highly potent, functional CCR3 antagonists.